Clinical Trials Logo

Clinical Trial Summary

This is a single site, prospective, non-blinded, non-randomized, before/after study. This study is designed to evaluate the impact of monitoring and reversal guidelines for neuromuscular blocking drugs on the post-operative outcomes for patients undergoing laparoscopic gastric bypass surgery.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05886218
Study type Observational
Source University of California, Davis
Contact Ana P Arias, BS
Phone 916-703-5456
Email apaarias@ucdavis.edu
Status Recruiting
Phase
Start date February 8, 2023
Completion date July 2024

See also
  Status Clinical Trial Phase
Recruiting NCT04997759 - Comparative Efficacy and Safety of Sugammadex and Neostigmine N/A
Recruiting NCT05794503 - Postoperative Urinary Retention After Reversal of Neuromuscular Block by Neostigmine Versus Sugammadex Early Phase 1
Not yet recruiting NCT05751603 - Effectiveness on Smooth Extubation According to the Administration Time of Sugammadex N/A
Completed NCT05066035 - Residual Paralysis and Reversal With Routine Neostigmine Versus Half-dose Sugammadex and Routine Neostigmine Phase 4
Active, not recruiting NCT06081738 - Neostigmine Versus Sugammadex on Renal Functions Phase 4
Completed NCT04471376 - The Effect of Sugammadex During Transcranial Electrical Motor Evoked Potential Monitoring in Spinal Surgery N/A
Recruiting NCT05028088 - Diaphragm Ultrasound to Evaluate the Antagonistic Effect of Sugammadex Phase 4
Completed NCT04332627 - Comparison of QoR-15 in Laparoscopic Cholecystectomy: Sugammadex vs. Neostigmine Phase 4
Completed NCT04608682 - Effect of Muscle Relaxation Reversal on the Success Rate of Motor Evoked Potential Recording N/A
Recruiting NCT04566796 - Effectiveness of Sugammadex on Muscle Relaxant Reversal in Preterm Neonates N/A